Sign in

CIK 0001534969

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
261911522
Phone
+1 801-990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,563
in 6 filings

Net −$79,563. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-06-03 Kamdar Kim P. Director Grant or award · Stock Option (right to buy) +149,675 149,675
2022-06-03 Mirza Mansoor Raza Director Grant or award · Stock Option (right to buy) +149,675 149,675
2022-06-03 Phillips Joshua Director Grant or award · Stock Option (right to buy) +149,675 149,675
2022-06-01 Boniface John J. Chief Scientific Officer Exercise or conversion +1,000 $0.73 $730 69,310
2022-06-01 Boniface John J. Chief Scientific Officer Sale −1,000 $1.36 $1K 68,310
2022-06-01 Boniface John J. Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −1,000 2,844
2022-05-31 Boniface John J. Chief Scientific Officer Sale −2,725 $1.45 $4K 68,310
2022-05-24 Boniface John J. Chief Scientific Officer Sale −2,725 $1.54 $4K 71,035
2022-05-17 Boniface John J. Chief Scientific Officer Sale −2,725 $1.55 $4K 73,760
2022-05-10 Boniface John J. Chief Scientific Officer Sale −2,725 $1.97 $5K 76,485
2022-05-04 Boniface John J. Chief Scientific Officer Exercise or conversion +1,000 $0.73 $730 80,210
2022-05-04 Boniface John J. Chief Scientific Officer Sale −1,000 $2.17 $2K 79,210
2022-05-04 Boniface John J. Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −1,000 3,844
2022-05-03 Boniface John J. Chief Scientific Officer Sale −2,725 $2.17 $6K 79,210
2022-04-26 Boniface John J. Chief Scientific Officer Sale −2,725 $2.17 $6K 81,935
2022-04-19 Boniface John J. Chief Scientific Officer Sale −2,725 $2.08 $6K 84,660
2022-04-12 Boniface John J. Chief Scientific Officer Sale −2,725 $2.66 $7K 87,385
2022-04-11 Barlow Jane F Director Grant or award · Stock Option (right to buy) +140,823 140,823
2022-04-06 Boniface John J. Chief Scientific Officer Exercise or conversion +1,000 $0.73 $730 91,110
2022-04-06 Boniface John J. Chief Scientific Officer Sale −1,000 $3.02 $3K 90,110

Page 19 of 23 · 457 trades